OLMA
Olema Pharmaceuticals Inc
NASDAQ: OLMA · HEALTHCARE · BIOTECHNOLOGY
$7.49
+6.39% today
Updated 2026-10-28
Market cap
$601.11M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.12
Dividend yield
—
52W range
$6 – $36
Volume
1.2M
Olema Pharmaceuticals Inc (OLMA) Insider transactions
Net insider activity
Net buying (4,168,442 shares)
Buy transactions
54
Sell transactions
46
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-01 | O'BYRNE, JASON | CHIEF FINANCIAL OFFICER | Buy | 650,000 | — | — |
| 2026-07-24 | HARMON, CYRUS | Director | Sale | 12,500 | $11.71 | $146425.00 |
| 2026-07-23 | HARMON, CYRUS | Director | Sale | 12,500 | $11.58 | $144737.50 |
| 2026-06-18 | RAPPAPORT, ANDREW | Director | Buy | 29,500 | — | — |
| 2026-06-18 | RAMAN, PRAKASH | Director | Buy | 29,500 | — | — |
| 2026-06-18 | LARSON, YI | Director | Buy | 29,500 | — | — |
| 2026-06-18 | HRUSTANOVIC, GORJAN | Director | Buy | 29,500 | — | — |
| 2026-06-18 | HORNING, SANDRA | Director | Buy | 29,500 | — | — |
| 2026-06-18 | HARMON, CYRUS | Director | Buy | 29,500 | — | — |
| 2026-06-18 | GRAHAM, G. WALMSLEY | Director | Buy | 29,500 | — | — |
| 2026-06-18 | GARLAND, J. SCOTT | Director | Buy | 29,500 | — | — |
| 2026-06-18 | CLARK, IAN T | Director | Buy | 29,500 | — | — |
| 2026-06-18 | BVF, PARTNERS L P/IL | Director, See Explanation of Responses | Buy | 29,500 | — | — |
| 2026-06-18 | BUTITTA, CYNTHIA M | Director | Buy | 29,500 | — | — |
| 2026-04-28 | RAMAN, PRAKASH | Director | Buy | 24,150 | — | — |
| 2026-04-28 | RAMAN, PRAKASH | Director | Buy | 2,911 | — | — |
| 2026-03-04 | MITCHELL, SHAWNTE | CHIEF LEGAL OFFICER | Sale | 25,000 | — | — |
| 2026-03-04 | MITCHELL, SHAWNTE | CHIEF LEGAL OFFICER | Sale | 233 | $24.69 | $5752.77 |
| 2026-03-04 | MITCHELL, SHAWNTE | CHIEF LEGAL OFFICER | Buy | 25,000 | $4.37 | $109250.00 |
| 2026-03-04 | MITCHELL, SHAWNTE | CHIEF LEGAL OFFICER | Sale | 24,767 | $24.25 | $600599.75 |
| 2026-03-03 | MITCHELL, SHAWNTE | CHIEF LEGAL OFFICER | Sale | 15,000 | — | — |
| 2026-03-03 | MITCHELL, SHAWNTE | CHIEF LEGAL OFFICER | Buy | 15,000 | $4.37 | $65550.00 |
| 2026-02-02 | ZOJWALLA, NASEEM | CHIEF MEDICAL OFFICER | Buy | 250,000 | — | — |
| 2026-02-02 | ZOJWALLA, NASEEM | CHIEF MEDICAL OFFICER | Buy | 106,250 | — | — |
| 2026-02-02 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Buy | 250,000 | — | — |
| 2026-02-02 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Buy | 106,250 | — | — |
| 2026-02-02 | MITCHELL, SHAWNTE | CHIEF LEGAL OFFICER | Buy | 220,000 | — | — |
| 2026-02-02 | MITCHELL, SHAWNTE | CHIEF LEGAL OFFICER | Buy | 56,250 | — | — |
| 2026-02-02 | BOHEN, SEAN | Director, PRESIDENT AND CEO | Buy | 850,000 | — | — |
| 2026-02-02 | BOHEN, SEAN | Director, PRESIDENT AND CEO | Buy | 275,000 | — | — |
| 2026-02-02 | AUSTIN, SASHA LU | VP of Finance and Controller | Buy | 29,250 | — | — |
| 2026-02-02 | AUSTIN, SASHA LU | VP of Finance and Controller | Buy | 11,700 | — | — |
| 2026-01-20 | HARMON, CYRUS | Director | Sale | 10,000 | $26.88 | $268800.00 |
| 2026-01-15 | KOVACS, SHANE WILLIAM CHARLES | CH. OPERATING & FINANCIAL OFF. | Sale | 100,000 | $28.73 | $2.87M |
| 2026-01-14 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 50,000 | — | — |
| 2026-01-14 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Buy | 50,000 | $4.87 | $243500.00 |
| 2026-01-14 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 35,003 | $28.99 | $1.01M |
| 2026-01-14 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 14,997 | $28.60 | $428914.20 |
| 2026-01-14 | HARMON, CYRUS | Director | Sale | 3,489 | $29.12 | $101599.68 |
| 2026-01-13 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 50,000 | — | — |
| 2026-01-13 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Buy | 50,000 | $4.87 | $243500.00 |
| 2026-01-13 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 49,800 | $27.60 | $1.37M |
| 2026-01-13 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 200 | $28.49 | $5698.00 |
| 2026-01-13 | KOVACS, SHANE WILLIAM CHARLES | CH. OPERATING & FINANCIAL OFF. | Sale | 3,822 | $28.01 | $107054.22 |
| 2026-01-12 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 10,000 | $28.34 | $283400.00 |
| 2025-12-26 | BOHEN, SEAN | Director, President and CEO | Sale | 8,500 | — | — |
| 2025-12-23 | ZOJWALLA, NASEEM | Chief Medical Officer | Sale | 50,000 | — | — |
| 2025-12-23 | ZOJWALLA, NASEEM | Chief Medical Officer | Sale | 99,509 | $27.66 | $2.75M |
| 2025-12-23 | ZOJWALLA, NASEEM | Chief Medical Officer | Buy | 50,000 | $7.02 | $351000.00 |
| 2025-12-22 | ZOJWALLA, NASEEM | Chief Medical Officer | Sale | 42,818 | — | — |
| 2025-12-22 | ZOJWALLA, NASEEM | Chief Medical Officer | Sale | 7,182 | — | — |
| 2025-12-22 | ZOJWALLA, NASEEM | Chief Medical Officer | Sale | 100,000 | $28.04 | $2.80M |
| 2025-12-22 | ZOJWALLA, NASEEM | Chief Medical Officer | Buy | 42,818 | $15.25 | $652974.50 |
| 2025-12-22 | ZOJWALLA, NASEEM | Chief Medical Officer | Buy | 7,182 | $7.02 | $50417.64 |
| 2025-12-22 | HARMON, CYRUS | Director | Sale | 2,881 | $28.53 | $82194.93 |
| 2025-12-19 | ZOJWALLA, NASEEM | Chief Medical Officer | Sale | 40,000 | — | — |
| 2025-12-19 | ZOJWALLA, NASEEM | Chief Medical Officer | Sale | 57,079 | $28.03 | $1.60M |
| 2025-12-19 | ZOJWALLA, NASEEM | Chief Medical Officer | Buy | 40,000 | $15.25 | $610000.00 |
| 2025-12-19 | ZOJWALLA, NASEEM | Chief Medical Officer | Sale | 12,921 | $28.93 | $373804.53 |
| 2025-12-19 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 43,729 | $30.40 | $1.33M |
| 2025-12-19 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 9,000 | — | — |
| 2025-12-19 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 6,046 | $31.39 | $189783.94 |
| 2025-12-19 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Sale | 1,225 | $28.08 | $34398.00 |
| 2025-12-19 | CLARK, IAN T | Director | Sale | 209,690 | — | — |
| 2025-12-19 | CLARK, IAN T | Director | Sale | 21,520 | — | — |
| 2025-12-19 | CLARK, IAN T | Director | Sale | 12,070 | — | — |
| 2025-12-19 | CLARK, IAN T | Director | Buy | 209,690 | $4.41 | $923894.14 |
| 2025-12-19 | CLARK, IAN T | Director | Sale | 193,056 | $29.71 | $5.74M |
| 2025-12-19 | CLARK, IAN T | Director | Sale | 41,840 | $30.48 | $1.28M |
| 2025-12-19 | CLARK, IAN T | Director | Sale | 29,904 | $28.83 | $862132.32 |
| 2025-12-19 | CLARK, IAN T | Director | Buy | 21,520 | $7.84 | $168716.80 |
| 2025-12-19 | CLARK, IAN T | Director | Buy | 12,070 | $4.08 | $49245.60 |
| 2025-12-08 | KOVACS, SHANE WILLIAM CHARLES | CH. OPERATING & FINANCIAL OFF. | Sale | 75,000 | — | — |
| 2025-11-26 | KOVACS, SHANE WILLIAM CHARLES | CH. OPERATING & FINANCIAL OFF. | Sale | 225,000 | — | — |
| 2025-11-25 | RAPPAPORT, ANDREW | Director | Sale | 35,868 | — | — |
| 2025-11-21 | RAPPAPORT, ANDREW | Director | Sale | 35,868 | — | — |
| 2025-11-21 | RAPPAPORT, ANDREW | Director | Buy | 35,868 | $0.39 | $13988.52 |
| 2025-09-18 | HARMON, CYRUS | Director | Sale | 10,000 | $8.33 | $83300.00 |
| 2025-09-18 | HARMON, CYRUS | Director | Sale | 3,086 | $8.32 | $25675.52 |
| 2025-09-16 | HARMON, CYRUS | Director | Sale | 10,000 | $8.04 | $80400.00 |
| 2025-09-16 | HARMON, CYRUS | Director | Sale | 1,914 | $8.08 | $15465.12 |
| 2025-06-11 | RAPPAPORT, ANDREW | Director | Buy | 24,150 | — | — |
| 2025-06-11 | LARSON, YI | Director | Buy | 24,150 | — | — |
| 2025-06-11 | HRUSTANOVIC, GORJAN | Director | Buy | 24,150 | — | — |
| 2025-06-11 | HORNING, SANDRA | Director | Buy | 24,150 | — | — |
| 2025-06-11 | HARMON, CYRUS | Director | Buy | 24,150 | — | — |
| 2025-06-11 | GRAHAM, G. WALMSLEY | Director | Buy | 24,150 | — | — |
| 2025-06-11 | GARLAND, J. SCOTT | Director | Buy | 24,150 | — | — |
| 2025-06-11 | CLARK, IAN T | Director | Buy | 24,150 | — | — |
| 2025-06-11 | BVF, PARTNERS L P/IL | Director, See Explanation of Responses | Buy | 24,150 | — | — |
| 2025-06-11 | BUTITTA, CYNTHIA M | Director | Buy | 24,150 | — | — |
| 2025-02-28 | ZOJWALLA, NASEEM | CHIEF MEDICAL OFFICER | Buy | 205,000 | — | — |
| 2025-02-28 | MYLES, DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | Buy | 205,000 | — | — |
| 2025-02-28 | MITCHELL, SHAWNTE | CHIEF LEGAL OFFICER | Buy | 450,000 | — | — |
| 2025-02-28 | KOVACS, SHANE WILLIAM CHARLES | CH. OPERATING & FINANCIAL OFF. | Buy | 320,000 | — | — |
| 2025-02-28 | BOHEN, SEAN | Director, PRESIDENT AND CEO | Buy | 650,000 | — | — |
| 2025-01-10 | BVF, PARTNERS L P/IL | Director, See Explanation of Responses | Buy | 235,450 | — | — |
| 2025-01-10 | BVF, PARTNERS L P/IL | Director, See Explanation of Responses | Buy | 161,810 | — | — |
| 2025-01-10 | BVF, PARTNERS L P/IL | Director, See Explanation of Responses | Buy | 22,740 | — | — |
| 2025-01-10 | BVF, PARTNERS L P/IL | Director, See Explanation of Responses | Sale | 235,450 | — | — |
Frequently asked questions
Are OLMA insiders buying or selling?
Over the transactions on record, OLMA insiders have been net buyers, with about $24.60M in stock sold across 46 sales, against 12 open-market purchases.
Does insider selling at OLMA mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which OLMA insiders are selling the most?
Recent selling is concentrated in a few names. CLARK, IAN T accounts for the largest share on record, with about $7.87M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.